Recently, radiation induced necrosis in the brain has been treated using bevacizumab, an anti-VEGF antibody. We validated the VEGF specificity by comparing the therapeutic efficacy of anti-VEGF with non-specific isotype control antibody. Additionally, we found that VEGF over-expression and RN developed simultaneously, which precludes preventative anti-VEGF treatment.
Keywords: Magnetic resonance imaging; Radiation necrosis; Vascular endothelial growth factor.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.